Vitreous fluorophotometry in juvenile diabetes. 1980

A Kernell, and Y Larsson, and J Ludvigsson, and T Tenland

A group of 26 juvenile diabetics, 8-22 years old with a mean duration of diabetes of 7.8 +/- 5.7 years were examined by vitreous fluorophotometry. Eleven non-diabetic healthy individuals, 12-27 years old, served as controls. Vitreous fluorescein concentrations one hour after injection of fluorescein were higher in the diabetics than in the controls indicating an abnormal blood-retinal barrier. In diabetes beyond the partial remission period a pronounced leakage of fluorescein into the vitreous body occurred, while diabetics still in partial remission showed no such abnormal leakage. There were no significant correlations between a defect blood-retinal barrier and duration or age at onset of diabetes. Some diabetic patients showed an abnormal leakage with a duration of diabetes less than 2 years, while some other patients with a duration of more than 16 years did not have an abnormal blood-retinal barrier. The diabetics with defect blood-retinal barrier had a lower glucosuria index during the last year, indicating a more inadequate metabolic control than those patients who had a normal barrier. There was no relation between the actual blood-glucose value during the examination and abnormal leakage. In some diabetics, all beyond partial remission significantly elevated fluorescein concentrations were also found in the anterior parts of the vitreous body, indicating a break-down of the blood-aqueous barrier as well. In conclusion, vitreous fluorophotometry provides information about early, functional and possibly reversible retinal changes in juvenile diabetes. The observation that the blood-retinal barrier remained intact during the remission period supports the hypothesis that normoglycemic metabolic control is of importance for the preservation of a normal blood-retinal barrier function.

UI MeSH Term Description Entries
D007908 Lens, Crystalline A transparent, biconvex structure of the EYE, enclosed in a capsule and situated behind the IRIS and in front of the vitreous humor (VITREOUS BODY). It is slightly overlapped at its margin by the ciliary processes. Adaptation by the CILIARY BODY is crucial for OCULAR ACCOMMODATION. Eye Lens,Lens, Eye,Crystalline Lens
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003930 Diabetic Retinopathy Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION. Diabetic Retinopathies,Retinopathies, Diabetic,Retinopathy, Diabetic
D005260 Female Females
D005452 Fluoresceins A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays. Tetraiodofluorescein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Kernell, and Y Larsson, and J Ludvigsson, and T Tenland
May 1978, Archives of ophthalmology (Chicago, Ill. : 1960),
A Kernell, and Y Larsson, and J Ludvigsson, and T Tenland
January 1979, Ophthalmology,
A Kernell, and Y Larsson, and J Ludvigsson, and T Tenland
January 1981, Developments in ophthalmology,
A Kernell, and Y Larsson, and J Ludvigsson, and T Tenland
October 1979, Archives of ophthalmology (Chicago, Ill. : 1960),
A Kernell, and Y Larsson, and J Ludvigsson, and T Tenland
November 1986, Archives of ophthalmology (Chicago, Ill. : 1960),
A Kernell, and Y Larsson, and J Ludvigsson, and T Tenland
January 1983, Nippon Ganka Gakkai zasshi,
A Kernell, and Y Larsson, and J Ludvigsson, and T Tenland
September 1979, American journal of ophthalmology,
A Kernell, and Y Larsson, and J Ludvigsson, and T Tenland
January 1981, Transactions of the ophthalmological societies of the United Kingdom,
A Kernell, and Y Larsson, and J Ludvigsson, and T Tenland
March 1982, Annals of ophthalmology,
A Kernell, and Y Larsson, and J Ludvigsson, and T Tenland
August 1987, Archives of ophthalmology (Chicago, Ill. : 1960),
Copied contents to your clipboard!